Pharmaceutical companies breathed a sigh of relief on Wednesday, but the tariff reprieve could prove fleeting.
Denmark's Bavarian Nordic said on Monday the U.S. Food and Drug Administration has approved a freeze-dried formulation of its ...
European shares rebounded on Tuesday from a two-month low touched in the previous session, while the market braced for an ...
3d
GlobalData on MSNFDA approves Bavarian Nordic’s freeze-dried mpox and smallpox vaccineThe formulation allows for greater stockpiling, with Bavarian Nordic already working with the US Government to add to vaccine ...
By Medha Singh and Sukriti Gupta (Reuters) -European shares rebounded on Tuesday after touching a two-month low in the ...
This recent safety and effectiveness data regarding mpox vaccination with Jynneos is important and timely given the ongoing ...
Explore more
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS ...
The FDA has approved a new freeze-dried formulation of Jynneos (smallpox and mpox vaccine, live, non-replicating).
A new report from GlobalData has raised concerns over the effectiveness of mpox vaccines for people living with HIV. Findings ...
COPENHAGEN, Denmark, March 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced that the U.S. Food and Drug Administration (FDA) has approved the freeze-dried formulation of JYNNEOS ...
COPENHAGEN, Denmark, March 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced that the U.S. Food and Drug Administration (FDA) has approved the freeze-dried formulation of JYNNEOS ® (Smallpox ...
COPENHAGEN, Denmark, March 31, 2025 - Bavarian Nordic A/S (OMX: BAVA) today announced that the U.S. Food and Drug Administration (FDA) has approved the freeze-dried formulation of JYNNEOS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results